OIRA Conclusion of EO 12866 Regulatory Review


RIN: 0651-AD02         View EO 12866 Meetings Received Date: 07/20/2016 
Title: Setting and Adjusting Patent Fees during Fiscal Year 2017 
Agency/Subagency: DOC / PTO   Stage: Proposed Rule 
Concluded Action: Consistent with Change  Concluded Date: 09/14/2016 
Legal Deadline: None  Economically Significant: Yes 
Publication Date: 10/03/2016  Unfunded Mandates: No 
Major: Yes  Related To Homeland Security: No 
Regulatory Flexibility Analysis Required: Yes  Small Entities Affected: Businesses, Organizations 
Federalism Implications: No  Affordable Care Act [Pub. L. 111-148 & 111-152]: No
International Impacts: No Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No
Pandemic Response: Uncollected